United States onlyOur mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Pharma Business Development team focuses on exploring the applications of Ginkgo’s platform in the therapeutics and vaccines space, and building partnerships that reflect Ginkgo’s business objectives. The business development team is an integral part of a cross-functional team, including technical, marketing, deal transaction, IP and legal teams, and Commercial operations that drive collaborations from conception, through negotiation and, ultimately, to signing.
Ginkgo has programs spanningengineering gene therapy capsids to improve transduction, enhance tissue tropism and reduce immunogenicity with Selecta Bio; synthetic biotics for treatment of homocystinuria with Synlogic; enzymatic therapies for orphan and rare diseases with Selecta Bio; gene therapy manufacturing with Biogen; biologics manufacturing platform with Novo Nordisk and small molecules for undruggable targets with Boehringer Ingelheim.
We are building a therapeutic modality agnostic platform through our partnerships and also acquiring relevant capabilities and IP, such as StrideBio’s AAV Capsid discovery and engineering platform assets:
“Fierce Biotech: Ginkgo Bioworks doesn’t want the biotech industry’s therapies. But it does want the platforms that create them”.
Job Description
In this role, as a member of the Pharma Business Development team you are responsible for building the partnering strategy, identifying areas and partners where our platform in collaborations with partners can address gaps in therapeutic modalities that enable our partners to address key unmet patient needs. You will be leading the expansion of Ginkgo’s partnership with large pharma companies, from conceptualization of partnership frameworks to being the long-term relationship owner for shepherding collaborations.
Responsibilities
Accountable for deal targets to grow Ginkgo’s partnerships with large Pharma enterprise accounts.
Build and execute enterprise account strategy for pharma enterprise accounts and cultivate new collaboration deal opportunities.
Collaborate closely with the deal transaction team to lead agreement discussions, structure deals and lead deal negotiations with potential partners; in addition to leading deals, support and mentor BD team members with deal sourcing, deal structuring and negotiations.
Grow Ginkgo’s network within the Pharma ecosystem including within large pharma companies.
Represent Ginkgo at industry events and shape the SynBio agenda across the industry.
Travel, as necessary, for conferences or partner meetings.
Minimum Requirements
Minimum Bachelor’s degree in engineering, and/or science; a PhD and Master degree in life science will be a plus.
Typically 8-10+ YOE plus PhD (or equivalent experience with a Bachelor's), including proven experience growing and developing a team to deliver results
Demonstrated account management track record, with existing strong relationships across large pharma partnering organizations and experience in negotiating complex deals to build meaningful research collaboration partnerships with large pharma companies.
Business development experience with deal sheets including research collaborations with large pharma companies.
Preferred Capabilities and Experience
Deep understanding of the drug discovery and development across multiple modalities; with a preference for greater expertise in drug discovery.
Recognized business leader in biopharma pre-clinical research and development partnering.
Preference for sell-side business development experience to large pharma organizations.
Demonstrated networks to CSOs, Heads of Research, and Business Development at biotech and large pharma companies.
Prior experience within a fast-growth company or entrepreneurial environment is a plus.
Excellent communication and presentation skills, with the ability to partner effectively with the executive team and cross-functional leaders throughout the company and communicate thoughtfully to diverse stakeholders.
Demonstrated commitment, self-motivation, and drive, and enthusiasm about being a part of Ginkgo’s mission.
Total compensation for this role is market driven, with a starting salary of $180K+, as well as company stock awards. Base pay is ultimately determined based on a candidate's skills, expertise, and experience. We also offer a comprehensive benefits package including medical, dental & vision coverage, health spending accounts, voluntary benefits, leave of absence policies, Employee Assistance Program, 401(k) program with employer contribution, 8 paid holidays in addition to a full-week winter shutdown and unlimited Paid Time Off policy.
To learn more about Ginkgo, visit www.ginkgobioworks.com/press/ or check out some curated press below:- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
